HBM Holdings (FRA:6XY) Total Liabilities : €90.02 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is HBM Holdings Total Liabilities?

HBM Holdings's Total Liabilities for the quarter that ended in Jun. 2024 was €90.02 Mil.

HBM Holdings's quarterly Total Liabilities declined from Jun. 2023 (€113.67 Mil) to Dec. 2023 (€99.82 Mil) and declined from Dec. 2023 (€99.82 Mil) to Jun. 2024 (€90.02 Mil).

HBM Holdings's annual Total Liabilities increased from Dec. 2021 (€52.61 Mil) to Dec. 2022 (€131.80 Mil) but then declined from Dec. 2022 (€131.80 Mil) to Dec. 2023 (€99.82 Mil).

HBM Holdings Total Liabilities Historical Data

The historical data trend for HBM Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HBM Holdings Total Liabilities Chart

HBM Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

200.65

22.79

52.61

131.80

99.82

HBM Holdings Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Liabilities	Get a 7-Day Free Trial							105.49	131.80	113.67	99.82	90.02

HBM Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

HBM Holdings's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	58.807	+	(26.206	+	14.803
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	99.82

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	209.516	-	109.7
	=	99.82

HBM Holdings's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	54.566	+	(20.399	+	15.054
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	90.02

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	204.107	-	114.088
	=	90.02

HBM Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of HBM Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

HBM Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HBM Holdings Ltd (FRA:6XY) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

HBMHF:USA 02142:Hong Kong

Address

218 Xinghu Street, Suite 202, Building A3, Suzhou Industrial Park, Suzhou, CHN, 215123

Website

https://www.harbourbiomed.com

HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. The majority of the revenue for the firm is generated from the United States.

HBM Holdings Headlines

No Headlines